Envista Holdings (NVST) Other Non-Current Assets (2018 - 2026)
Envista Holdings (NVST) recorded quarterly Other Non-Current Assets of $223.8 million in Q2 2026, down 1.89% quarter-over-quarter from $228.1 million in Q4 2025, and down 8.54% on a YoY basis from $244.7 million in Q2 2025.
Envista Holdings (NVST) Other Non-Current Assets (2018 - 2026) Analysis & Trends
Envista Holdings' Other Non-Current Assets history runs 9 years deep, the most recent figure standing at $223.8 million for Q2 2026.
- In Q2 2026, Other Non-Current Assets fell 8.54% year-over-year to $223.8 million; the TTM figure through Apr 2026 stood at $223.8 million (down 8.54% YoY), while the FY2025 annual figure was $228.1 million, down 1.08% from the prior year.
- Other Non-Current Assets was $223.8 million for Q2 2026 at Envista Holdings, down from $228.1 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $264.9 million in Q2 2025 to a low of $4.1 million in Q3 2022.
- Historically, Other Non-Current Assets has averaged $191.3 million across 5 years, with a median of $199.5 million in 2023.
- The sharpest annual moves came in 2022 and 2023: Other Non-Current Assets sank 97.21% in 2022, then soared 3600.0% in 2023.
- A 5-year view of Other Non-Current Assets shows it stood at $153.7 million in 2022, then climbed by 17.44% to $180.5 million in 2023, then climbed by 27.76% to $230.6 million in 2024, then slipped by 1.08% to $228.1 million in 2025, then retreated by 1.89% to $223.8 million in 2026.
- The last three Other Non-Current Assets figures came in at $223.8 million (Q2 2026), $228.1 million (Q4 2025), and $249.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | - |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 2.43 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 446.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 210.73 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 81.30 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 848.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 672.80 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 39.83 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 692.00 Mn |
| 10 | Envista Holdings | 4.06 Bn | 2.98 Bn | 390.10 Mn | 223.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 223.80 Mn |
| Dec 31, 2025 | 228.10 Mn |
| Sep 26, 2025 | 249.30 Mn |
| Jun 27, 2025 | 264.90 Mn |
| Mar 28, 2025 | 244.70 Mn |
| Dec 31, 2024 | 230.60 Mn |
| Sep 27, 2024 | 250.60 Mn |
| Jun 28, 2024 | 218.60 Mn |
| Mar 29, 2024 | 174.40 Mn |
| Dec 31, 2023 | 180.50 Mn |
| Sep 29, 2023 | 152.90 Mn |
| Jun 30, 2023 | 151.70 Mn |
| Mar 31, 2023 | 158.30 Mn |
| Dec 31, 2022 | 153.70 Mn |
| Jul 1, 2022 | 4.10 Mn |
| Apr 1, 2022 | 174.90 Mn |
| Dec 31, 2021 | 12.20 Mn |
| Jul 2, 2021 | 147.00 Mn |
| Apr 2, 2021 | 127.00 Mn |
| Dec 31, 2020 | 113.90 Mn |